Molecular persistent spectral image (Mol-PSI) representation for machine learning models in drug design

• Published in: Briefings in bioinformatics Vol. 23; no. 1
• Main Authors: Jiang, Peiran, Chi, Ying, Li, Xiao-Shuang, Meng, Zhenyu, Liu, Xiang, Hua, Xian-Sheng, Xia, Kelin
• Format: Journal Article
• Language: English
• Published: England Oxford University Press 17.01.2022; Oxford Publishing Limited (England)
• Subjects: Artificial Intelligence; Artificial neural networks; Biological properties; Data analysis; Design; Drug Design; Drug development; Learning algorithms; Ligands; Machine Learning; Models, Molecular; Models, Theoretical; Molecular modelling; Molecular Structure; Neural networks; Neural Networks, Computer; Pharmaceutical industry; Protein Binding - drug effects; Representations; Three dimensional models; protein-ligand binding; persistent spectral; molecular representation; convolutional neural networks
• ISSN: 1467-5463; 1477-4054
• DOI: 10.1093/bib/bbab527

Abstract Artificial intelligence (AI)-based drug design has great promise to fundamentally change the landscape of the pharmaceutical industry. Even though there are great progress from handcrafted feature-based machine learning models, 3D convolutional neural networks (CNNs) and graph neural networks, effective and efficient representations that characterize the structural, physical, chemical and biological properties of molecular structures and interactions remain to be a great challenge. Here, we propose an equal-sized molecular 2D image representation, known as the molecular persistent spectral image (Mol-PSI), and combine it with CNN model for AI-based drug design. Mol-PSI provides a unique one-to-one image representation for molecular structures and interactions. In general, deep models are empowered to achieve better performance with systematically organized representations in image format. A well-designed parallel CNN architecture for adapting Mol-PSIs is developed for protein–ligand binding affinity prediction. Our results, for the three most commonly used databases, including PDBbind-v2007, PDBbind-v2013 and PDBbind-v2016, are better than all traditional machine learning models, as far as we know. Our Mol-PSI model provides a powerful molecular representation that can be widely used in AI-based drug design and molecular data analysis.